A randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma. [electronic resource]
Producer: 20121126Description: 4706-14 p. digitalISSN:- 1097-0142
- Adult
- Aged
- Analysis of Variance
- Antibodies, Monoclonal -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Carmustine -- administration & dosage
- Cytarabine -- administration & dosage
- Disease-Free Survival
- Drug Administration Schedule
- Early Termination of Clinical Trials
- Etoposide -- administration & dosage
- Female
- Humans
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Melphalan -- administration & dosage
- Middle Aged
- Odds Ratio
- Prognosis
- Proportional Hazards Models
- Recurrence
- Risk Factors
- Sample Size
- Stem Cell Transplantation
- Survival Analysis
- Transplantation Conditioning -- methods
- Transplantation, Autologous
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.